Table 4.
Comparing BS, SPECT and SPECT/CT in lesion-based analysis of 96 knee lesions
| BS vs SPECT vs SPECT/CT (n = 96) | ||||
| Modality | Number of lesions (%) | Difference (BS vs SPECT) | Difference (BS vs SPECT/CT) | Difference (SPECT vs SPECT/CT) |
| Localisation | ||||
| BS | 40 (41.7%) | } 40 (41.7%) } P < 0.001 | } 56 (58.3%) P < 0.001 } | |
| SPECT | 80 (83.3%) | } 16 (16.7%) } P < 0.001 | ||
| SPECT/CT | 96 (100%) | |||
| Characterisation | ||||
| BS | 50 (52.1%) | } 4 (4.2%) } P > 0.1 | } 43 (44.8%) P < 0.001 } | |
| SPECT | 54 (56.2%) | } 39 (40.6%) } P < 0.001 | ||
| SPECT/CT | 93 (96.9%) | |||
| BS vs SPECT vs SPECT/CT (excluding arthropathy lesions n = 48) | ||||
| Modality | Number of lesions detected (%) | Difference (BS vs SPECT) | Difference (BS vs SPECT/CT) | Difference (SPECT vs SPECT/CT) |
| Characterisation | ||||
| BS | 3 (6.25%) | } 3 (6.25%) } P > 0.2 | } 42 (87.5%) P < 0.001 } | |
| SPECT | 6 (12.5%) | } 39 (81.25%) } P < 0.001 | ||
| SPECT/CT | 45 (93.75%) | |||